Parvalbumin-immunoreactive neurons in the hippocampal formation of Alzheimer's diseased brain

Neuroscience

Volumn 80, Issue 4, 1997, Pages 1113-1125

  Brady, D R ^a,c   Mufson, E J ^b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

Author keywords

Ca2+ buffering agent; Degeneration; Dentate gyrus; Immunocytochemistry; Presubiculum; Subiculum

Indexed keywords

PARVALBUMIN; THIOFLAVINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; GRANULE CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTERNEURON; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; SUBICULUM;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DENTATE GYRUS; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NERVE FIBERS; NEURONS; PARVALBUMINS; PYRAMIDAL CELLS; REFERENCE VALUES;

EID: 0030814682     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00068-7     Document Type: Article

References (45)

1. Amaral D. G. and Campbell M. J. (1986) Transmitter systems in the primate dentate gyrus. Hum. Neurobiol. 5, 169-180.
2. Arai H., Emson P. C., Mountjoy C. O., Carassco L. H. and Heizmann C. W. (1987) Loss of parvalbumin immunoreactive neurons from cortex in Alzheimer-type dementia. Brain Res. 418, 164-169.
3. Berchtold M. W., Celio M. R. and Heizmann C. W. (1985) Parvalbumin in human brain. J. Neurochem. 45, 234-239.
4. Braak E., Strotkamp B. and Braak H. (1991) Parvalbumin-immunoreactive structures in the hippocampus of the human adult. Cell Tissue Res. 264, 33-48.
5. Brady D. R. and Mufson E. J. (1990) Amygdaloid pathology in Alzheimer's disease: qualitative and quantitative analysis. Dementia 1, 5-17.
6. Brady D. R. and Mufson E. J. (1991) Alz50 immunoreactive neuropil differentiates hippocampal complex subfields in Alzheimer's disease. J. comp. Neurol. 305, 489-507.
7. Celio M. R. (1986) Parvalbumin in most γ-aminobutyric acid-containing neurons of the rat cerebral cortex. Science 231, 995-997.
8. Celio M. R. (1990) Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 35, 375-475.
9. Chan-Palay V. (1987) Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: coexistence with neuropeptide Y neuronism, and effects in Alzheimer-type dementia. J. comp. Neurol. 260, 201-223.
10. Chan-Palay V., Kohler C., Haesler U., Lang W. and Yasargil G. (1986) Distribution of neurons and axons immunoreactive with anti-sera against neuropeptide Y in the normal human hippocampus. J. comp. Neurol. 248, 360-375.
11. Dawbarn D., Rossor M. N., Mountjoy C. O., Roth M. and Emson P. C. (1986) Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type. Neurosci. Lett. 70, 154-159.
12. DeFelipe J., Hendry S. H. C. and Jones E. G. (1989) Visualization of chandelier cell axons by parvalbumin immunoreactivity in monkey cerebral cortex. Proc. natn. Acad. Sci. U.S.A. 86, 2093-2097.
13. Ferrer I., Soriano E., Tunon T., Fonseca M. and Guionnet N. (1991) Parvalbumin immunoreactive neurons in normal human temporal neocortex and in patients with Alzheimer's disease. J. neurol. Sci. 106, 135-141.
14. Ferrer I., Zujar M. J., Rivera R., Soria M., Vidal A. and Casas R. (1993) Parvalbumin-immunoreactive dystrophic neurites and aberrant sprouts in the cerebral cortex of patients with Alzheimer's disease. Neurosci. Lett. 158, 163-166.
15. Fonseca M., Soriano E., Ferrer I., Martinez A. and Tunon T. (1993) Chandelier cell axons identified by parvalbumin-immunoreactivity in the normal human temporal cortex and in Alzheimer's disease. Neuroscience 55, 1107-1116.
16. Caspar P., Duyckaerts E., Ferret A., Benoit R., Beck B. and Berger B. (1989) Subpopulations of somatostatin-28 immunoreactive neurons display different vulnerability in senile dementia of the Alzheimer type. Brain Res. 490, 1-13.
17. Griffin W. S., Stanley L. C., Ling C., White L., MacLeod V., Perrot L. J., White C. L. and Araoz C. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 86, 7611-7615.
18. Hochli M., Zetzsche T. and Chan-Palay V. (1991) Parvalbumin immunoreactive neurons in the normal human hippocampus. Dementia 2, 243-258.
19. Hof P. R., Cox K., Young W. G., Celio M. R., Rogers J. and Morrison J. H. (1991) Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease. J. Neuropath. exp. Neurol. 50, 451-462.
20. Hooper M. W. and Vogel F. S. (1976) The limbic system in Alzheimer's disease. J. Path. 85, 1-19.
21. Hyman B. T., Van Hoesen G. W., Damasio A. R. and Barnes C. L. (1984) Alzheimer's disease: cell specific pathology isolates the hippocampal formation. Science 225, 1168-1170.
22. Inaguma Y., Shinohara H., Inagaki T. and Kato K. (1992) Immunoreactive parvalbumin concentration in parahippocampal gyrus decreases in patients with Alzheimer's disease. J. neurol. Sci. 110, 57-61.
23. Iwamoto N. and Emson P. C. (1991) Demonstration of neurofibrillary tangles in parvalbumin-immunoreactive interneurones in the cerebral cortex of Alzheimer-type dementia brain. Neurosci. Lett. 128, 81-84.
24. Katsumara H., Kosaka T., Heizmann C. W. and Hama K. (1988) Immunocytochemical study of GABAergic neurons containing calcium-binding protein parvalbumin in rat hippocampus. Expl Brain Res. 72, 347-362.
25. Khachaturian Z. S. (1985) Diagnosis of Alzheimers disease. Arch. Neurol. 42, 1097-1105.
26. Leifer D. and Kowall N. W. (1993) Immunohistochemical patterns of selective cellular vulnerability in human cerebral ischemia. J. neurol. Sci. 119, 217-228.
27. Lorente de No R. (1934) Studies on the structure of the cerebral cortex. II. Continuation of the study of the ammonic system. J. Psychol. Neurol. 46, 113-177.
28. Lotstra F. and Vanderhaeghen J. J. (1987) Distribution of immunoreactive cholecystokinin in the human hippocampus. Peptides 8, 911-920.
29. Mirra S. S., Hart M. N. and Terry R. (1993) Making the diagnosis of Alzheimers disease. Arch. Path. Lab. Med. 117, 132-144.
30. Nitsch R. and Leranth C. (1991) Neuropeptide Y (NPY)-immunoreactive neurons in the primate fascia dentata: occasional coexistence with calcium-binding proteins: a light and electronmicroscopic study. J. comp. Neurol. 309, 430-440.
31. Nitsch R., Leranth C. and Frotscher M. (1990) Most somatostatin immunoreactive neurons in the rat fascia dentata do not contain the calcium-binding protein parvalbumin. Brain Res. 528, 327-329.
32. ++-binding protein parvalbumin. Neurosci. Lett. 105, 263-268.
33. Ohshima T., Endo T. and Onaya T. (1991) Distribution of parvalbumin immunoreactivity in the human brain. J. Neurol. 238, 320-322.
34. Pearson R. C. A., Esiri M. M., Hiorns R. W., Wilcock G. K. and Powell T. P. S. (1985) Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc. natn. Acad. Sci. U.S.A. 82, 4531-4534.
35. Pitkanen A. and Amaral D. G. (1993) Distribution of parvalbumin immunoreactive cells and fibers in the monkey temporal lobe: the hippocampal formation. J. comp. Neurol. 331, 37-74.
36. Ramon y Cajal S. R. (1968) Studies on the Cerebral Cortex (Irans. Kraft L. N.). Year Book Publications, Chicago, IL.
37. Rosene D. L. and Van Hoesen G. W. (1977) Hippocampal efferents reach widespread areas of cerebral cortex and amygdala in rhesus monkey. Science 198, 315-317.
38. Satoh J., Tabira T., Sano M., Nakayama H. and Tateishi J. (1991) Parvalbumin-immunoreactive neurons in the human central nervous system are decreased in Alzheimer's disease. Acta neuropath., Berl. 81, 388-395.
39. Scharfman H. E. and Schwarzkroin P. A. (1989) Protection of dentate hilar mossy cells from prolonged stimulation by intracellular calcium chelation. Science 246, 257-260.
40. Seress L., Gulyas A. I., Ferrer I., Tunon T., Soriano E. and Freund T. F. (1993) Distribution, morphological features, and synaptic connections of parvalbumin- and calbindin D28k-immunoreactive neurons in the human hippocampal formation. J. comp. Neurol. 337, 208-230.
41. Sloviter R. S., Sollas A. L., Barbaro N. M. and Laxer K. D. (1991) Calcium-binding protein (calbindin-D28k) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus. J. comp. Neurol. 308, 381-396.
42. Stichel C. C., Singer W., Heizmann C. W. and Normal A. W. (1987) Immunohistochemical localization of calcium-binding proteins parvalbumin and calbindin D-28k in the adult and developing visual cortex of cats: a light and electronmicroscopic study. J. comp. Neurol. 262, 563-577.
43. Waldvogel H. J., Faull R. L. M., Williams M. N. and Dragunon M. (1991) Differential sensitivity of calbindin and parvalbumin immunoreactive cells in the striatum to excitotoxins. Brain Res. 546, 329-335.
44. Watson R. E. Jr, Wiegand S. J., Clough R. W. and Hoffman C. E. (1986) Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptide 7, 155-159.
45. Witter M. P., Van Hoesen G. W. and Amaral D. G. (1989) Topographical organization of the entorhinal projection to the dentate gyrus of the monkey. J. Neurosci. 9, 216-228.